University Of Vermont
Clinical trials sponsored by University Of Vermont, explained in plain language.
-
New combo therapy aims to tame AML without harsh chemo
Disease control ENROLLING_BY_INVITATIONThis study tests whether adding the anti-inflammatory drug dexamethasone to a standard low-intensity therapy (venetoclax plus another chemo drug) is safe and tolerable for adults with newly diagnosed acute myeloid leukemia (AML) who cannot have intensive chemotherapy. About 20 pa…
Phase: PHASE1 • Sponsor: University of Vermont • Aim: Disease control
Last updated May 01, 2026 16:01 UTC
-
Needle injection of chemo into lung tumors shows promise in early trial
Symptom relief OngoingThis early-phase study tests a method to inject the chemotherapy drug cisplatin directly into lung tumors using a bronchoscope (EBUS-guided needle). The goal is to find the highest safe dose for people with stage IV lung cancer. Only 16 participants are enrolled, and the main foc…
Phase: PHASE1 • Sponsor: University of Vermont • Aim: Symptom relief
Last updated Apr 30, 2026 15:48 UTC
-
New program aims to prevent dangerous blood clots in cancer patients
Knowledge-focused ENROLLING_BY_INVITATIONThis study tests whether a modified clinical program can improve how doctors prevent blood clots (venous thromboembolism) in cancer patients receiving treatment. About 25 clinicians and their patients will take part. The program includes education for doctors and requires them to…
Phase: NA • Sponsor: University of Vermont • Aim: Knowledge-focused
Last updated May 01, 2026 16:00 UTC